Skip to content

Study · Measured the body's own peptide · 2013

2 results

Identification of thymosins β4 and β 10 in paediatric craniopharyngioma cystic fluid.

Desiderio C, Martelli C, Rossetti DV, Di Rocco C, D'Angelo L, Caldarelli M, Tamburrini G, Iavarone F, Castagnola M, Messana I, Cabras T, Faa G

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery17 Mar 2013Cited by 19 (Europe PMC)

PMID23503632 (opens in a new tab)DOI10.1007/s00381-013-2069-9 (opens in a new tab)PepBankPUB-23503632
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    Thymosin beta‑4 and beta-10 were not found in the cerebrospinal fluid available for two patients.

    In plain wordsThe body's own thymosin beta‑4 was not found in the spinal fluid of two patients.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicablePresence in cerebrospinal fluid
    Study

    n = 2

    Paediatric adamantinomatous craniopharyngioma intracystic fluid
    Outcome group
    Endogenous peptide levels · Cancer

    Source sentences

    Summary
    These peptides were not found in the cerebrospinal fluid available for two patients.
    1 context sentence
    Summary · context
    Intracystic fluid was analysed by a LC-ESI-IT-MS top-down platform after acidification, deproteinization and chloroform liquid/liquid extraction.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In paediatric adamantinomatous craniopharyngioma, thymosin beta‑4 and beta-10 were present in 77 % of the analysed intracystic fluid samples.

    In plain wordsIn children with this brain tumour, the body's own thymosin beta‑4 was found in 77 % of cyst fluid samples.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicablePresence in intracystic fluid
    Study

    n: not reported in source

    Paediatric adamantinomatous craniopharyngioma intracystic fluid
    Outcome group
    Endogenous peptide levels · Cancer

    Measurements

    Samples with thymosin beta-4 and beta-10 present
    77%
    intracystic fluid

    Source sentences

    Summary
    Thymosin β4 and β10 were present in 77 % of the analysed samples.
    1 context sentence
    Summary · context
    Intracystic fluid was analysed by a LC-ESI-IT-MS top-down platform after acidification, deproteinization and chloroform liquid/liquid extraction.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.